Raia Drogasil (OTCMKTS:RADLY) Releases Quarterly Earnings Results, Hits Expectations

Raia Drogasil (OTCMKTS:RADLY) issued its quarterly earnings results on Tuesday. The company reported $0.05 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.05, Zacks reports. The business had revenue of $2.22 billion during the quarter, compared to analyst estimates of $2.43 billion. Raia Drogasil had a net margin of 2.89% and a return on equity of 20.61%.

Raia Drogasil Price Performance

Shares of RADLY opened at $2.81 on Thursday. The stock has a 50 day simple moving average of $3.70 and a 200 day simple moving average of $4.06. Raia Drogasil has a 52-week low of $2.63 and a 52-week high of $5.34. The company has a debt-to-equity ratio of 0.99, a quick ratio of 0.58 and a current ratio of 1.41. The firm has a market capitalization of $3.70 billion and a PE ratio of 14.98.

Analysts Set New Price Targets

Separately, Jefferies Financial Group raised shares of Raia Drogasil to a “buy” rating and set a $5.20 price objective on the stock in a research note on Sunday, October 18th. One research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, Raia Drogasil currently has a consensus rating of “Moderate Buy” and a consensus target price of $5.20.

Raia Drogasil Company Profile

Raia Drogasil, now operating under the name RD Saúde, is a Brazilian healthcare and pharmacy retail company. It operates a network of pharmacies offering prescription medicines, over-the-counter drugs, vitamins, personal care products, beauty items and other health-related merchandise.

The company also provides digital purchasing and delivery services through its online channels, supporting customers with prescription fulfillment, health products and related services. Its operations include pharmacy-based healthcare initiatives designed to complement its retail business and improve access to everyday healthcare.

RD Saúde was created in 2011 through the merger of Drogasil and Droga Raia, two established Brazilian pharmacy chains.